Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 17 citing articles:

Precision medicine using molecular-target drugs in psoriatic arthritis
Ippei Miyagawa, Yoshiya Tanaka
Therapeutic Advances in Musculoskeletal Disease (2025) Vol. 17
Open Access
Analytical and Clinical Validation of the Plasma-Based Guardant360 CDx Test for Assessing HER2 (ERBB2) Mutation Status in Patients with Non–Small-Cell Lung Cancer for Treatment with Trastuzumab Deruxtecan in DESTINY-Lung01/02
Zhenhao Qi, Shinya Tokuhiro, Justin I. Odegaard, et al.
Journal of Molecular Diagnostics (2025) Vol. 27, Iss. 2, pp. 119-129
Closed Access
Artificial intelligence for diagnosis and predictive biomarkers in Non-Small cell lung cancer Patients: New promises but also new hurdles for the pathologist
Paul Hofman, Iordanis Ourailidis, Eva Romanovsky, et al.
Lung Cancer (2025) Vol. 200, pp. 108110-108110
Closed Access
Molecular testing of lung cancer in Australia: consensus best practice recommendations from the Royal College of Pathologists of Australasia in collaboration with the Thoracic Oncology Group of Australasia
Wendy A. Cooper, Benhur Amanuel, Caroline Cooper, et al.
Pathology (2025)
Open Access
Caractérisation moléculaire des cancers du poumon : mise au point et recommandations
Simon Garinet, Audrey Mansuet‐Lupo, Diane Damotte, et al.
Bulletin du Cancer (2025) Vol. 112, Iss. 3, pp. 3S16-3S23
Closed Access
‘Fit-for-Purpose Testing’ of Pd-L1 Status in Patient Selection for Pembrolizumab Therapy in Nscc by Sp263 Assay & 22c3 Laboratory Developed Test, Using 22c3 Pharmdx Fda Approved Assay for Indirect Diagnostic Validation
Gurudutt Gupta, Ankur Kumar, Anila Sharma, et al.
(2025)
Closed Access
PD‐L1 Scoring Models for Non‐Small Cell Lung Cancer in China: Current Status, AI‐Assisted Solutions and Future Perspectives
Ziling Huang, Shen Wang, Jiansong Zhou, et al.
Thoracic Cancer (2025) Vol. 16, Iss. 7
Open Access
Histopathological evidence of cellular alterations in the dentate gyrus is associated with aberrant RB1CC1-ATG16L1 expression in the hippocampus among older adults with chronic schizophrenia: A pilot post-mortem study
Andreas S. Lappas, Μαρία Ιωάννου, George N. Christodoulou
Schizophrenia Research (2024) Vol. 275, pp. 14-24
Closed Access | Times Cited: 2
Towards enhancing the predictive value of the microbiota for cancer immunotherapy
Amiran Dzutsev, Romina S. Goldszmid
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 771-773
Closed Access | Times Cited: 1
Pathologische Diagnostik und Biomarker für die perioperative Systemtherapie
Ramona Erber
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie (2024) Vol. 149, Iss. S 01, pp. S13-S25
Closed Access | Times Cited: 1
Predicting the tumor microenvironment composition and immunotherapy response in non-small cell lung cancer from digital histopathology images
Sushant Patkar, Alex Chen, Alina Basnet, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Biomarkers for immunotherapy resistance in non-small cell lung cancer
Catriona Rother, Thomas John, Annie Wong
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology Images
Sushant Patkar, Alex Chen, Alina Basnet, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pathways to Precision: Guideline for Programmed Death Ligand-1 and Tumor Mutation Burden Testing to Support the Selection of Immune Checkpoint Therapies in Lung Cancer
Matthew J. Cecchini
Archives of Pathology & Laboratory Medicine (2024) Vol. 148, Iss. 7, pp. 754-756
Open Access
Application of the 5th WHO Guidelines for the Diagnosis of Lung Carcinoma in Small Lung Biopsies in a Tertiary Care Center: Is Insecurity of Pathologists for the Accurate Diagnosis Justified?
Manuela Beckert, Christian F. Meyer, Thomas Papadopoulos, et al.
Diagnostics (2024) Vol. 14, Iss. 18, pp. 2090-2090
Open Access
Assessment of PD-L1 expression and tumour infiltrating lymphocytes in early-stage non-small cell lung carcinoma with artificial intelligence algorithms
Aída Molero, Susana Hernández, Marta Alonso de la Varga, et al.
Journal of Clinical Pathology (2024), pp. jcp-209766
Open Access
Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC
Michelle Shiller, Melissa L. Johnson, Robert P. Auber, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Page 1

Scroll to top